Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancerMarina Elena Cazzaniga, Maureen Trudeau, Foluso O. Ademuyiwa et al.|JNCI Cancer Spectrum|2023Cited by 3
Advanced High-Grade Serous Ovarian Cancer Treated With Intensive Cytoreductive Surgery And Chemotherapy: Prognostic Impact Of Lymph Node Involvement: Analysis Of The French National ESME-Unicancer DatabaseCécile Loaec, Barnabé Bouvarel, Quentin Dominique Thomas et al.|International Journal of Gynecological Cancer|2025Cited by 0